Kaveri Seed Q2 FY27 slides show recovery amid export surge, weather drag

Kaveri Seed’s Q2 FY27 revenue rose 29.84% year over year to ₹125.44 crore, EBITDA turned positive at ₹5.42 crore, and net loss narrowed to ₹3.21 crore; shares nevertheless fell 2.91% to $680 after the update. H1 revenue declined 9.7% to ₹940.44 crore as El Niño-related rainfall deficits and lower sowing acreage weighed on demand, while maize revenue fell 36.3%; export revenue grew 2.63 times to ₹33.07 crore. Management expects H2 standalone revenue to be flat to up 10%, but flagged elevated inventory and persistent near-term maize weakness; the board also approved subsidiaries in eight countries and declared an interim dividend of ₹5 per share.

Analysis

The key risk is not the near-term revenue miss or beat; it is whether elevated maize inventory converts to saleable product before quality deterioration or another weak sowing cycle. Halting production limits further buildup, but shifts the next kharif recovery into a test of inventory age, germination quality and farmer demand. If write-offs emerge, margin and cash conversion could disappoint together. The fall in cash alongside inventory growth makes working capital a more useful near-term signal than reported earnings.

Export growth and new hybrids offer diversification, but the eight-country buildout is a multi-year option, not an FY27 earnings offset: registration timelines defer meaningful revenue while adding execution costs. Do not capitalize that ambition as near-term growth. The reported Q2 and H1 revenue figures also warrant a scope/reconciliation check before drawing sequential conclusions; confirm standalone versus consolidated basis and segment disclosures.

Horizon: In the next 1–3 months, monitor cash, inventory aging/quality and H2 guidance delivery. Over 6–18 months, recovery depends on maize acreage and seed sell-through, while cotton product gains and exports could improve mix. Weather, illegal cotton-seed competition, and weak farmer economics can reverse the recovery. The contrarian opportunity is that the market may be discounting a cyclical rebound too aggressively—but there is not yet enough evidence to underwrite it. No high-conviction directional trade today; inventory monetization is the gating signal.

Key Decisions for Investors

• Stay neutral on Kaveri Seed pending the next disclosure; do not treat the export expansion or H1 export growth as a near-term earnings catalyst.
• Set an alert for the next results: require evidence of maize inventory drawdown without material quality losses, alongside stabilization in cash/working capital, before considering a long. Falsification: rising inventory, cash deterioration, or write-offs.
• Track next kharif maize acreage and farmer sentiment, plus cotton sell-through against illegal-seed competition. A broad acreage recovery without company-level inventory conversion is not sufficient confirmation.
• Before comparing quarterly and half-year trends, verify whether the cited revenue figures use the same standalone/consolidated scope and reconcile them to reported filings.